373 records, the earliest from 21 Oct 2022. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
373 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Category | Subject |
|---|---|---|
| 1 Oct 2026 | Company Update | Piramal Pharma Ltd - 543635 - Clarification On News Item Which Appeared In The 'Www.Thehindubusinessline.Com' Dated September 30, 2026 Captioned 'Ontario Contributes $1.7 Million Investment To Advance Life Sciences Innovation At Piramal Pharma'S Aurora Facility.' |
| 1 Oct 2026 | Company Update | Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Expiry And Non-Renewal Of Commercial Arrangement With Bayer Pharmaceuticals Private Limited |
| 1 Oct 2026 14:41 | Updates | Piramal Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 - Expiry and Non-Renewal of CommercialArrangement with Bayer Pharmaceuticals Private Limited'. |
| 1 Oct 2026 13:44 | News Verification | The Exchange has sought clarification from Piramal Pharma Limited with respect to recent news item captioned Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharmas Aurora Facility.. The response from the Company is attached. |
| 30 Sep 2026 | Company Update | Piramal Pharma Ltd - 543635 - Clarification sought from Piramal Pharma Ltd |
| 30 Sep 2026 | Company Update | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Management |
| 30 Sep 2026 | Company Update | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Management |
| 30 Sep 2026 14:43 | Change in Management | Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 Appointment of Senior Management Personnel |
| 30 Sep 2026 12:30 | Change in Management | Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 Changes in Senior Management Personnel |
| 30 Sep 2026 12:26 | News Verification | The Exchange has sought clarification from Piramal Pharma Limited with respect to recent news item captioned Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharmas Aurora Facility.. The response from the Company is awaited. |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
